[HTML][HTML] Minimally invasive radical pancreatectomy for left-sided pancreatic cancer: current status and future perspectives
CM Kang, SH Lee, WJ Lee - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Minimally invasive distal pancreatectomy with splenectomy has been regarded as a safe
and effective treatment for benign and borderline malignant pancreatic lesions. However, its …
and effective treatment for benign and borderline malignant pancreatic lesions. However, its …
Left-sided pancreatic cancer: distal pancreatectomy and its variants: radical antegrade modular pancreatosplenectomy and distal pancreatectomy with celiac axis …
SM Strasberg, R Fields - The Cancer Journal, 2012 - journals.lww.com
Adenocarcinoma of the body and tail of the pancreas is an aggressive malignancy, and
classically there have been few survivors after surgery. Radical antegrade modular …
classically there have been few survivors after surgery. Radical antegrade modular …
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF (IRIN) OX-based chemotherapy-a multicenter, non-comparative, randomized, phase II trial (PANACHE01 …
L Schwarz, D Vernerey, JB Bachet, JJ Tuech… - BMC cancer, 2018 - Springer
Background At time of diagnosis, less than 10% of patients with pancreatic
adenocarcinomas (PDAC) are considered to be immediately operable (ie resectable) …
adenocarcinomas (PDAC) are considered to be immediately operable (ie resectable) …
Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure
BACKGROUND: The radical antegrade modular pancreatosplenectomy (RAMPS)
procedure is a modification of standard distal pancreatosplenectomy. It was designed to …
procedure is a modification of standard distal pancreatosplenectomy. It was designed to …
Hypoxia induces TWIST-activated epithelial–mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice
S Chen, J Chen, J Zhang, H Chen, M Yan, L Huang… - Cancer letters, 2016 - Elsevier
The epithelial–mesenchymal transition (EMT) plays a crucial role in pancreatic ductal
adenocarcinoma (PDAC) development and progression. TWIST activated by intra-tumoral …
adenocarcinoma (PDAC) development and progression. TWIST activated by intra-tumoral …
Pattern of lymph node metastasis spread in pancreatic cancer
Objectives: We aimed to clarify the detailed pattern of lymph node (LN) metastasis spread in
patients with pancreatic cancer. Methods: This retrospective study enrolled 429 patients who …
patients with pancreatic cancer. Methods: This retrospective study enrolled 429 patients who …
Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer
T Sugiura, K Uesaka, K Mihara, K Sasaki, H Kanemoto… - Surgery, 2013 - Elsevier
Background Controversy persists as to whether positive operative margins are an
independent prognostic factor for resected pancreatic cancer. This study evaluated the …
independent prognostic factor for resected pancreatic cancer. This study evaluated the …
Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection?
K Okada, M Kawai, M Tani, S Hirono, M Miyazawa… - Surgery, 2013 - Elsevier
BACKGROUND: Indications for distal pancreatectomy with en-bloc celiac axis resection (DP-
CAR) in pancreatic carcinoma remain controversial. METHODS: Fifty-two consecutive …
CAR) in pancreatic carcinoma remain controversial. METHODS: Fifty-two consecutive …
Comparison of surgical outcomes between radical antegrade modular pancreatosplenectomy (RAMPS) and standard retrograde pancreatosplenectomy (SPRS) for …
T Abe, K Ohuchida, Y Miyasaka, T Ohtsuka, Y Oda… - World journal of …, 2016 - Springer
Background Radical antegrade modular pancreatosplenectomy (RAMPS) is a modification
of standard retrograde pancreatosplenectomy (SRPS) used to achieve the dissection of N1 …
of standard retrograde pancreatosplenectomy (SRPS) used to achieve the dissection of N1 …
Impact of neoadjuvant therapy in resected pancreatic ductal adenocarcinoma of the pancreatic body or tail on surgical and oncological outcome: a propensity-score …
S Lof, M Korrel, J van Hilst, A Alseidi, G Balzano… - Annals of Surgical …, 2020 - Springer
Background Several studies have suggested a survival benefit of neoadjuvant therapy
(NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data …
(NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data …